Literature DB >> 5371667

[Rifomycin levels in the lung and tuberculous lesions in man].

G Canetti, R Parrot, G Porven, M Le Lirzin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5371667

Source DB:  PubMed          Journal:  Acta Tuberc Pneumol Belg        ISSN： 0001-7078


× No keyword cloud information.
  10 in total

1.  Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.

Authors:  Maria C Kjellsson; Laura E Via; Anne Goh; Danielle Weiner; Kang Min Low; Steven Kern; Goonaseelan Pillai; Clifton E Barry; Véronique Dartois
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

Review 2.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

Authors:  Daniel T Hoagland; Jiuyu Liu; Robin B Lee; Richard E Lee
Journal:  Adv Drug Deliv Rev       Date:  2016-05-02       Impact factor: 15.470

Review 3.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

4.  Rifampicin in plasma and pleural fluid after single oral doses.

Authors:  G Boman; A S Malmborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 5.  The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

Authors:  Véronique Dartois
Journal:  Nat Rev Microbiol       Date:  2014-02-03       Impact factor: 60.633

Review 6.  Advances in Drug Discovery and Development for Pediatric Tuberculosis.

Authors:  Daniel Hoagland; Ying Zhao; Richard E Lee
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 7.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

Review 8.  Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Authors:  Lloyd Tanner; Paolo Denti; Lubbe Wiesner; Digby F Warner
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

9.  Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda.

Authors:  Beth Temple; Irene Ayakaka; Sam Ogwang; Helen Nabanjja; Susan Kayes; Susan Nakubulwa; William Worodria; Jonathan Levin; Moses Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Peter G Smith; Roy D Mugerwa; Jerrold J Ellner; Edward C Jones-López
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

Review 10.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.